Log in to save to my catalogue

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Associa...

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Associa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_16b27802f7ac4fbb84a8b7ac98844da8

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance

About this item

Full title

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance

Publisher

Switzerland: MDPI

Journal title

Current issues in molecular biology, 2022-09, Vol.44 (9), p.4132-4141

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

Without the proper information on pyrazinamide (PZA) susceptibility of Mycobacterium tuberculosis (MTB), PZA is inappropriately recommended for the treatment of both susceptible and multidrug-resistant tuberculosis (MDR-TB) in Nepal. This study aimed to collect information regarding PZA susceptibility in MTB isolates from Nepal by analyzing pncA an...

Alternative Titles

Full title

Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_16b27802f7ac4fbb84a8b7ac98844da8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_16b27802f7ac4fbb84a8b7ac98844da8

Other Identifiers

ISSN

1467-3045,1467-3037

E-ISSN

1467-3045

DOI

10.3390/cimb44090283

How to access this item